Riskpilot← Back to searchSign inGet full accessXanaCare AB
ABActiveOrg 5590979547Kittelvägen 22General medical practice activities · NACE 8621Est. 20170 employees
Revenue 2025
SEK 0
EBITDA margin
—
Equity ratio
—
Financial strength
Net profit 2025
SEK 0
+100% vs 2024
| Revenue | SEK 0 | — |
| EBITDA | — | — |
| Net profit | SEK 0 | +100% |
| Total assets | SEK 0 | — |
| Equity | SEK 0 | +100% |
| Employees | 0 | — |
Legal name
XanaCare AB
Org number
5590979547
Legal form
Aktiebolag
NACE code
8621 · General medical practice activities
Founded
20 januari 2017
Share capital
SEK 0
Employees
0
VAT registered
Yes
Audit selected
No
Last report
2025-06-30
Financial year
January – December
Signatory rights
Firman tecknas av styrelsen
Company purpose
Bedriver konsultverksamhet inom hälso och sjukvård.
Address
Kittelvägen 22
Email
xanacare@hotmail.com
Risika for professionals
Risika provides regulated workflow tools for finance, procurement and compliance teams that need monitoring, alerts and an API.
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Revenue | 0 | 0 | 286 | 0 | 0 |
| Staff expenses | — | — | — | −6 | −0 |
| EBITDA | — | — | 201 | −96 | — |
| Depreciation & amort. | −0 | — | — | — | — |
| EBIT | 0 | 0 | 201 | −96 | 0 |
| Net financials | — | — | — | — | — |
| Profit before tax | 0 | 0 | 201 | −96 | 0 |
| Tax | −0 | — | — | — | — |
| Net profit | 0 | 0 | 201 | −96 | 0 |
| Item | 2021 | 2022 | 2023 | 2024 | 2025 |
|---|---|---|---|---|---|
| Total assets | 36 | 108 | 318 | 0 | 0 |
| Equity | 94 | 94 | 228 | −96 | 0 |
| Long-term debt | 58 | 14 | 14 | 96 | 0 |
| Short-term debt | 0 | −0 | 76 | 0 | 0 |
| Total debt | 58 | 14 | 90 | 96 | — |
EBITDA margin
0.0%
This company
15.8%
Market median
-100% vs market
20212025
Equity ratio
0.0%
This company
38.2%
Market median
-100% vs market
20212025
Return on equity
0.0%
This company
18.4%
Market median
-100% vs market
20212025
Net profit margin
0.0%
This company
8.1%
Market median
-100% vs market
20212025
Asset turnover
0.00×
This company
1.12×
Market median
-100% vs market
20212025
Debt / equity
-1.00×
This company
0.62×
Market median
+261% vs market
20212025
- Annual report 2025Filed via Bolagsverket / SCB · Period 2024-07-01 – 2025-06-30
- Annual report 2024Filed via Bolagsverket / SCB · Period 2023-07-01 – 2024-06-30
- Annual report 2023Filed via Bolagsverket / SCB · Period 2022-07-01 – 2023-06-30
- Annual report 2022Filed via Bolagsverket / SCB · Period 2021-07-01 – 2022-06-30
- Annual report 2021Filed via Bolagsverket / SCB · Period 2020-07-01 – 2021-06-30
| Name | Role | Member since |
|---|---|---|
| Current (1) | ||
BB Chief Executive Officer | Chief Executive Officer | 2022 |
| Name | Role | Member since |
|---|---|---|
| Current (2) | ||
| Deputy Board Member | 2022 | |
| Deputy Board Member | 2022 | |
No shareholder data available.
Beneficial ownership (UBO) data access is restricted in Denmark as of September 2025 per the EU 6th AML Directive. Learn more.
No registered parent or subsidiaries
Board members of XanaCare AB also hold positions in 0 other companies.
| Person | Role here | Other companies |
|---|---|---|
| Benjamin Biniam Yemane | Chief Executive Officer | 0 companies |
| Saba Mosazghi | Deputy Board Member | 0 companies |
| Hannibal Wegahta Yemane | Deputy Board Member | 0 companies |